Graham Colditz

Last updated

Graham Colditz
Born (1954-11-01) 1 November 1954 (age 68)
Sydney, Australia
Nationality Australian
Education Newington College
University of Queensland
Harvard University
Occupation(s)Niess-Gain Professor
Washington University School of Medicine
Associate Director
Alvin J. Siteman Cancer Center
SpousePat Cox
Children1 son, 1 daughter

Graham Andrew Colditz MD, DrPH (born 1 November 1954) is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center. [1] He directs the Master of Population Health Science at Washington University School of Medicine. [2] During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention, [3] and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening. [4] According to Google Scholar statistics, Colditz has a h-index of more than 300. [5]

Contents

Birth and education

Colditz was born in Australia and educated at Newington College (1967–72). [6] He was active in cricket and rugby at Newington. He received his B.Sc. and medical degree from the University of Queensland, Australia, where he served as President of the Australian Medical Students Association in 1977. He obtained his M.P.H. and Doctorate in Public Health from Harvard University School of Public Health. [7] Placing great importance on applying the scientific evidence amassed through research, Dr. Colditz has taken the lead on a number of large health communication projects, including the development of the long-running, popular health risk assessment, Your Disease Risk. [8] [9] At Siteman he leads efforts to promote cancer prevention in the community [10]

Awards and honors

Related Research Articles

<span class="mw-page-title-main">Harvard T.H. Chan School of Public Health</span> Public health institution

The Harvard T.H. Chan School of Public Health is the public health school of Harvard University, located in the Longwood Medical Area of Boston, Massachusetts. The school grew out of the Harvard-MIT School for Health Officers, the nation's first graduate training program in population health, which was founded in 1913 and then became the Harvard School of Public Health in 1922.

<span class="mw-page-title-main">Howard Koh</span> American physician

Howard Kyongju Koh is the former United States Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS), after being nominated by President Barack Obama and confirmed by the U.S. Senate in 2009.

<span class="mw-page-title-main">Washington University School of Medicine</span> Medical school of Washington University in St. Louis

Washington University School of Medicine (WUSM) is the medical school of Washington University in St. Louis, a private research university with its main campus in St. Louis County, and Clayton, Missouri. Founded in 1891, the School of Medicine shares a campus with Barnes-Jewish Hospital, Alvin J. Siteman Cancer Center, and Central Institute for the Deaf. It has consistently ranked among the top medical schools in the United States in terms of the number/amount of research grants/funding awarded by the National Institutes of Health, among other measures.

The Nurses' Health Study is a series of prospective studies that examine epidemiology and the long-term effects of nutrition, hormones, environment, and nurses' work-life on health and disease development. The studies have been among the largest investigations into risk factors for major chronic diseases ever conducted. The Nurses' Health Studies have led to many insights on health and well-being, including cancer prevention, cardiovascular disease, and type 2 diabetes. They have included clinicians, epidemiologists, and statisticians at the Channing Laboratory, Harvard Medical School, Harvard School of Public Health, and several Harvard-affiliated hospitals, including Brigham and Women's Hospital, Dana–Farber Cancer Institute, Children's Hospital Boston, and Beth Israel Deaconess Medical Center.

<span class="mw-page-title-main">Emil Frei</span> American physician and oncologist

Emil "Tom" Frei III was an American physician and oncologist. He was the former director and former physician-in-chief of the Dana–Farber Cancer Institute in Boston, Massachusetts. He was also the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School.

<span class="mw-page-title-main">JoAnn E. Manson</span>

JoAnn Elisabeth Manson is an American physician and professor known for her pioneering research, public leadership, and advocacy in the fields of epidemiology and women's health.

Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.

Dr. Sue J. Goldie is the Roger Irving Lee Professor of Public Health, the Director of the Center for Health Decision Science, Director of the Global Health Education and Learning Incubator at Harvard University, and founding Faculty Director of the Harvard Global Health Institute. Dr. Goldie has a secondary appointment as Professor of Global Health and Social Medicine. Her professional agenda includes improving women's health in all parts of the world, using evidence-based policy to reduce global health inequities, building bridges between disciplines to tackle critical public health challenges, and fostering innovation in education.

Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.

Robert Palmer Beasley was a physician, public health educator and epidemiologist whose work on hepatitis B involved extensive investigations in Taiwan. That work established that hepatitis B virus (HBV) is a primary cause of liver cancer and that hepatitis B virus is transmitted from mother to infant during childbirth. Beasley and his colleagues also proved that HBV mother-to-infant transmission is preventable by at-birth vaccination. Due to this work, the World Health Assembly designated HBV as the seventh global vaccine in 1992. He later became the author of HBV immunization policies for the World Health Organization.

Richard David Kolodner is an American scientist with Ludwig Cancer Research who has made research contributions to the genetic basis for inherited susceptibility to common cancers. He is a Distinguished Professor of Cellular and Molecular Medicine at the UC San Diego School of Medicine. Kolodner is a member of the National Academy of Sciences and National Academy of Medicine, and he is a fellow of the American Academy of Arts and Sciences.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

David M. Livingston was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. Dr. Livingston joined the Harvard faculty in 1973. His research focused on breast and ovarian cancer.

Michael B. Sporn is a professor emeritus of pharmacology, toxicology and medicine at Dartmouth Medical School. His research focuses on the prevention of cancer.

<span class="mw-page-title-main">Curtis C. Harris</span> American cancer researcher

Curtis. C. Harris is the head of the Molecular Genetics and Carcinogenesis Section and chief of the Laboratory of Human Carcinogenesis at the Center for Cancer Research of the National Cancer Institute, NIH.

Philip Greenberg is a Professor of Medicine, Oncology and Immunology at the University of Washington and Head of Program in Immunology at Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics and Affini-T.

Raymond N. DuBois is an American academic and scientist. He is the incumbent director of the Hollings Cancer Center at the Medical University of South Carolina and executive chairman of the board of the Mark Foundation for Cancer Research.

Mitchell H. Gail is an American physician-scientist and biostatistician. He is a distinguished investigator at the National Cancer Institute.

Susan Hankinson is an American cancer researcher who is the Distinguished Professor of Epidemiology at the University of Massachusetts Amherst. Her research considers cancer epidemiology and the etiology of breast cancer. Her work has demonstrated the relationship between hormones and breast cancer risk. In 2023, she was awarded the American Association for Cancer Research Award for Research Excellence in Cancer Epidemiology and Prevention.

References

  1. ↑ "Colditz, Graham".
  2. ↑ "Home". mphs.wustl.edu.
  3. ↑ "Cancer and the public health | Digital Outlook".
  4. ↑ "Home". cancernewsincontext.org.
  5. ↑ "Graham Colditz, MD, DrPH". Google Scholar. Retrieved 22 March 2023.
  6. ↑ Newington College Register of Past Students 1863-1998 (Syd, 1999) pp39
  7. ↑ "Graham A. Colditz MD, DRPH". Archived from the original on 5 February 2012. Retrieved 4 August 2012.
  8. ↑ "Home". yourdiseaserisk.wustl.edu.
  9. ↑ Colditz, Graham A.; Dart, Hank (2021). "Commentary: 20 years online with "Your Disease Risk"". Cancer Causes & Control. 32 (1): 5–11. doi:10.1007/s10552-020-01356-3. PMC   7796866 . PMID   33068181. S2CID   223559879.
  10. ↑ "Elimination of Cancer Disparities". Siteman Cancer Center.
  11. ↑ "2009 Alumni Award of Merit Winner Graham Colditz - Alumni Stories - Harvard Public Health Magazine - Harvard School of Public Health". Archived from the original on 11 December 2012. Retrieved 4 August 2012.
  12. ↑ "ACS Medal of Honor". Archived from the original on 12 September 2015. Retrieved 4 August 2012.
  13. ↑ http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2734%5B%5D
  14. ↑ "Colditz to be honored for cancer prevention efforts - the Source - Washington University in St. Louis". 19 March 2014.
  15. ↑ Newington Medal International Retrieved 24 August 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.